At Omega Medical Research, we pride ourselves on providing the most knowledgeable and experienced Principal Investigators to carry out our clinical research studies. Under the direction of our Medical Director, David L. Fried, MD, our investigators are well versed and well trained in the requirements and expectations in conducting clinical drug trials. All are knowledgeable regarding good clinical practices and all FDA requirements and responsibilities. Additionally, all are Board Certified in their specialty areas.
Get To Know Us
For more information please call.
David L. Fried, MD Medical Director/ Chief Principal Investigator
Dr. Fried serves as Medical Director for Omega Medical Research as well as the Principal Investigator on a significant number of our clinical drug trials. Dr. Fried has served in this capacity since 1996. Dr. Fried has been Principal Investigator on over 350 clinical drug trials. Dr. Fried is Board Certified in Internal Medicine and serves as a Clinical Assistant Professor of Medicine at Brown University.
Lynne A. Haughey, MSN, FNP-BC Executive Vice President/COO/ Sub-Investigator
Ms. Haughey has over 17 years of clinical research experience, having co-founded Omega Medical Research in 1993. Ms. Haughey serves as Sub-Investigator on most trials at Omega, with over 400 trials completed in this capacity. Additionally, Ms. Haughey oversees the clinical research staff of coordinators and assistants, the Patient Recruitment department and the Quality Assurance Program at Omega. Ms. Haughey previously served as the Director of Critical Care Nursing at Roger Williams Medical Center in Providence, RI and was the Director of Stratogen Health, a comprehensive HIV/AIDS patient care center, prior to founding Omega Medical Research.
Joseph F. Renzulli, II, MD
Dr. Renzulli is a certified robotic surgeon and a member of the prestigious Alpha Omega Alpha national medical honor society. He is a member of the urology staff at The Miriam Hospital and Rhode Island Hospital. Current research interests include the effects of neoadjuvant chemotherapy prior to prostatectomy for high-risk prostate cancer and mRNA transfer via microvesicles in prostate cancer. Dr. Renzulli has published in peer-reviewed journals and has presented at national and local meetings. He has served as Principal Investigator on many trials involving GU and Prostate Cancer.
Richard K. Ohnmacht, MD Pediatric Medicine
Dr. Ohnmacht is a Board Certified Pediatrician who has been in private practice since 1991. Dr. Ohnmacht has participated as a Principal Investigator at Omega Medical Research since 2001, having conducted over 25 pediatric research studies. Dr. Ohnmacht also serves as a Clinical Assistant Professor in Pediatrics at Brown University. In 1997, Dr. Ohnmacht was named Best Doctor in America/Northeast Region in Pediatric Medicine.
Eric B. Newton, MD Gastroenterology
Dr. Newton is Board Certified in both Internal Medicine and Gastroenterology. Dr. Newton is a member of University Gastroenterology and has been involved with clinical research since 2009.